63613-50-3

Propanoic acid, 2-(triphenylphosphoranylidene)-, phenylmethyl ester

Methanone, diphenyl-,O-[[5-(4-morpholinyl)-1,3,4-oxadiazol-2-yl]methyl]oxime

1,8-Naphthyridin-4(1H)-one,7-[(4-chlorophenyl)amino]-5-methyl-1-phenyl-2-(phenylamino)-

1,3-Propanediamine, N-nonyl-

10H-Phenoxarsine, 10-hexyl-

1,8-Naphthyridin-4(1H)-one,6-fluoro-7-(1-methylethoxy)-1-phenyl-2-(phenylamino)-

1,8-Naphthyridin-4(1H)-one,7-[(2S,6R)-2,6-dimethyl-4-morpholinyl]-6-fluoro-1-(3-fluorophenyl)-2-[(3-fluorophenyl)amino]-

1,8-Naphthyridin-4(1H)-one,7-(hydroxy-2-thienylmethyl)-5-methyl-1-phenyl-2-(phenylamino)-

1,8-Naphthyridin-4(1H)-one,7-methyl-6-(2-methylpropyl)-1-phenyl-2-(phenylamino)-,mono(trifluoroacetate)

1,8-Naphthyridine, 2-(4-chlorophenyl)-

1,8-Naphthyridin-4(1H)-one,7-methyl-6-(3-oxobutyl)-1-phenyl-2-(phenylamino)-

Octanamide, 8-amino-N-methyl-2-oxo-

1,8-dibromo-3,6-Bis(tert-butyl)carbazole

1,8-Naphthyridin-4(1H)-one,1-(4-fluorophenyl)-2-[(4-fluorophenyl)amino]-5-(trifluoromethyl)-

n-[(e)-(4-bromophenyl)methylene]quinolin-3-amine

1,8-Naphthyridin-4-ol, 2,7-dimethyl-3-(2,4,6-trifluorophenyl)-

1,8-Naphthyridin-2(1H)-one,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-[2-(3-thienyl)ethyl]-, monosodium salt

1,8-Naphthyridin-2(1H)-one,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-[(2S)-2-methylbutyl]-, monosodium salt

1,3-Propanediol, 1,3-dicyclohexyl-, (1S,3S)-

3-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-6-nitro-2H-chromen-2-one

2-phenyl-1-(2,2,4-trimethylquinolin-1(2H)-yl)ethanone

1,8-Naphthyridin-4(1H)-one,7-(2-methoxyethoxy)-1-phenyl-2-(phenylamino)-5-(trifluoromethyl)-

1,8-Naphthyridin-4(1H)-one, 1-[2-(dimethylamino)ethyl]-7-methyl-

L-Phenylalaninamide,N-[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]-D-phenylalanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(chloroacetyl)butyl]-

1,8-Naphthyridin-4(1H)-one,7-methyl-5-(1-methylethoxy)-1-phenyl-2-(phenylamino)-

1,8-Naphthyridin-2(1H)-one,4-chloro-3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-1-(phenylmethyl)-

Spiro[bicyclo[4.2.0]octane-7,1'-cyclohexan]-8-one

1,8-Naphthyridin-4(1H)-one,7-(3-amino-1-pyrrolidinyl)-6-fluoro-3-[[(1,2,3,4-tetrahydro-1-naphthalenyl)amino]methyl]-, mono(trifluoroacetate)

10H-Phenoxazin-3-ol, 4-methyl-

1,8-Naphthyridin-4(1H)-one,7-(3-amino-1-pyrrolidinyl)-3-[[[(3,4-difluorophenyl)methyl]amino]methyl]-6-fluoro-, mono(trifluoroacetate)

1,3-Propanediamine, N-[7-(3-bromophenyl)-1,6-naphthyridin-5-yl]-

1,8-Naphthyridin-4(1H)-one,1-(4-fluorophenyl)-2-[(4-fluorophenyl)amino]-7-[(2-methoxyethyl)amino]-5-methyl-

1,8-Naphthyridin-4(1H)-one,5-methyl-7-(1-oxobutyl)-1-phenyl-2-(phenylamino)-

10H-Phenoxazine, 1,2,3,4-tetrafluoro-

10H-Phenoxazine, 10-(2-furanylcarbonyl)-

1,8-Naphthyridin-4(1H)-one,7-(1-methylethoxy)-1-phenyl-2-(phenylamino)-5-(trifluoromethyl)-

1,8-Naphthyridin-2(1H)-one,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-[(6-methyl-2-pyridinyl)methyl]-

63613-50-3 msds

CAS No 63613-50-3 supplier

CASNo 63613-50-3 distributor

CAS # 63613-50-3 manufacturer

CAS Number 63613-50-3 safety

CAS RN 63613-50-3 wholesale

2026-10-09 Find Propanoic acid, 2-(triphenylphosphoranylidene)-, phenylmethyl ester,CAS No.63613-50-3,Formula:C28H25O2P in ChemToTech